FDA Clearance Accelerates Launch Of Innovative Minimally Invasive Sacroiliitis Treatment Industry Trends Gaining Momentum in the Global Sacroiliitis Treatment Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Sacroiliitis Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the sacroiliitis treatment market has markedly increased in size. The market, which is projected to expand from $1.64 billion in 2024 to $1.77 billion in 2025, will do so at a compound annual growth rate (CAGR) of 7.5%. The substantial growth experienced in the past can be credited to the escalating incidences of lower back pain, heightened demand for early diagnosis, increase in sports-induced pelvic injuries, enhanced utilization of cutting-edge imaging methods, and a growing emphasis on minimally invasive treatments.

Sacroiliitis Treatment Market Size Forecast: What's the Projected Valuation by 2029?
Anticipations are high for significant expansion of the sacroiliitis treatment market in the coming years. The market is poised to reach $2.33 billion by the end of 2029, growing at a compound annual growth rate (CAGR) of 7.2%. The projected growth in this period can be linked to an increase in research and development (R&D) investments for innovative treatments, a surge in the utilization of telemedicine for managing chronic pain, an elevated incidence of autoimmune diseases, the enhanced availability of specific biologic therapies, and a mounting demand for personalized medicine solutions. The forecast period also promises trends such as advancements in targeted drug delivery systems, the emergence of individualized treatment options, breakthroughs in regenerative medicine therapies, progression in robotic-assisted surgical operations, and the formulation of combination therapy protocols.

View the full report here:
https://www.thebusinessresearchcompany.com/report/sacroiliitis-treatment-global-market-report

What Are the Drivers Transforming the Sacroiliitis Treatment Market?
The surge in joint disorder cases is predicted to boost the expansion of the sacroiliitis treatment market. Joint disorders refer to conditions that impact the joints, leading to symptoms such as inflammation, pain, stiffness, and diminished movement, which can be caused by factors such as injury, old age, autoimmune diseases, and infections. The rise in the occurrence of joint disorders is mainly due to the aging population's natural wear and tear on their joints, which results in an increased frequency of diseases like osteoarthritis and other degenerative joint conditions. Sacroiliitis treatment is beneficial for those suffering from joint diseases as it aids in lowering inflammation and pain in the sacroiliac joints, enhances movement capability and overall joint function, helping to relieve symptoms and prevent additional joint damage. For example, in June 2024, the Australian Institute of Health and Welfare, an Australian governmental organization, reported that osteoarthritis, a chronic ailment resulting in joint cartilage deterioration, impacted around 2.1 million Australians (8.3%) in 2022, including 10% of women and 6.1% of men. Hence, the rise in joint disorder incidences is fuelling the growth of the sacroiliitis treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24688&type=smp

What Long-Term Trends Will Define the Future of the Sacroiliitis Treatment Market?
Prominent entities in the sacroiliitis treatment market are prioritizing regulatory authorization to expedite the introduction of novel therapies, ensure market penetration, and bolster their competitive status. Regulatory authorization implies the official approval from federal health bodies, confirming the safety and efficacy of the medical treatment for general use. For example, in December 2023, Spinal Simplicity, a medical equipment manufacturing firm based in the US, attained FDA 510(k) clearance for its Liberty-SI Lateral Implant System. This is a minimally invasive device made to induce sacroiliac joint fusion in patients suffering from conditions such as sacroiliac disruptions and degenerative sacroiliitis. The system employs a lateral approach, positioning one or two titanium implants through the ilium and across the SI joint into the sacrum for stabilisation and fusion. The implants comprise a central threaded body with deployable wings and compressive elements, come in various sizes, and are coated with hydroxyapatite for improved integration. The methodology is devised to be safer and less invasive, potentially minimizing anesthesia duration and enhancing patient results.

Which Segments in the Sacroiliitis Treatment Market Offer the Most Profit Potential?
The sacroiliitis treatment market covered in this report is segmented -

1) By Type: Medications, Joint Injections, Joint Fusion, Radiofrequency Denervation, Electrical Stimulation
2) By Diagnosis: Imaging Tests, Physical Examination, Laboratory Tests, Other Diagnosis
3) By Route Of Administration: Oral, Injectable, Topical
4) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:
1) By Medications: NSAIDs (Nonsteroidal Anti-Inflammatory Drugs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Agents, Analgesics
2) By Joint Injections: Corticosteroid Injections, Platelet-Rich Plasma (PRP) Injections, Hyaluronic Acid Injections, Prolotherapy
3) By Joint Fusion: Minimally Invasive SI Joint Fusion, Open SI Joint Fusion, Robotic-Assisted Fusion Techniques, Posterior Approach Fusion, Lateral Approach Fusion
4) By Radiofrequency Denervation: Conventional Radiofrequency Ablation, Cooled Radiofrequency Ablation, Pulsed Radiofrequency Ablation
5) By Electrical Stimulation: Transcutaneous Electrical Nerve Stimulation (TENS), Spinal Cord Stimulation (SCS), Peripheral Nerve Stimulation (PNS)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24688&type=smp

Which Firms Dominate the Sacroiliitis Treatment Market by Market Share and Revenue in 2025?
Major companies operating in the sacroiliitis treatment market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Biogen Inc., Sandoz Group AG, UCB S.A., Hikma Pharmaceuticals PLC, Samsung Bioepis Co. Ltd., Lupin Limited, Zydus Lifesciences Limited, Celltrion Healthcare Co. Ltd., Torrent Pharmaceuticals Limited, Globus Medical, Fortis Healthcare, Orthofix Medical Inc., Coherus BioSciences Inc., SI-BONE Inc.

Which Regions Offer the Highest Growth Potential in the Sacroiliitis Treatment Market?
North America was the largest region in the sacroiliitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacroiliitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24688

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.